Skip to main content

Squarepoint Ops LLC

Position in ESPR — Esperion Therapeutics, Inc.

CIK 1642575 NEW YORK, NY

Position in ESPR

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$0
+$0 QoQ
Shares Held
700,153
+135.9% QoQ
Ownership
0.272%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Dec 2020
18 quarters on record
Voting authority Sole 0% Shared 100% None 0%

Common Shares in ESPR Over Time

Shares Held

Position Value (USD)

Derivatives in ESPR

reported options exposure · as of Dec 31, 2024
CallValue
$0
CallShares
0
PutValue
$0
PutShares
98,900

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

Squarepoint Ops LLC holds $151,394,819 across 40 Drug Manufacturers - Specialty & Generic names.

# Ticker Company Shares Value (USD) Open

All Filings in ESPR

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-03-31 700,153
2025-09-30 296,811
2025-06-30 214,386
2025-03-31 877,408
2024-12-31 98,900
2024-12-31 339,032
2024-09-30 210,222
2024-03-31 300,300
2023-12-31 87,712
2023-09-30 27,969
2023-03-31 184,941
2022-12-31 131,536
2022-09-30 57,862
2022-06-30 48,065
2021-12-31 72,352
2021-09-30 72,499
2021-06-30 39,236
2021-03-31 19,545
2020-12-31 15,109